Atlas Trials

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Clinical trial NCT03224923 · TERMINATED

Trial details

NCT number
NCT03224923
Sponsor
Ottawa Heart Institute Research Corporation
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Stable Coronary SyndromePercutaneous Coronary InterventionAntiplatelet TherapyTicagrelor
Start date
2017-08-18
Primary completion
2018-09-30
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.